These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8441761)

  • 21. Cilazapril in congestive heart failure. A pilot study.
    Kiowski W; Drexler H; Meinertz T; Zuber M; Ritz R; Burkart F; Just H
    Drugs; 1991; 41 Suppl 1():54-61. PubMed ID: 1712273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive ventilation with continuous positive airway pressure acutely improves 6-minute walk distance in chronic heart failure.
    Chermont S; Quintão MM; Mesquita ET; Rocha NN; Nóbrega AC
    J Cardiopulm Rehabil Prev; 2009; 29(1):44-8. PubMed ID: 19158587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure.
    Aquilani R; Viglio S; Iadarola P; Opasich C; Testa A; Dioguardi FS; Pasini E
    Am J Cardiol; 2008 Jun; 101(11A):104E-110E. PubMed ID: 18514618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile.
    Prager G; Klein P; Schmitt M; Prager R
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S93-9. PubMed ID: 7700076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
    Blanchet M; Sheppard R; Racine N; Ducharme A; Curnier D; Tardif JC; Sirois P; Lamoureux MC; De Champlain J; White M
    Am Heart J; 2005 May; 149(5):938.e1-7. PubMed ID: 15894946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
    Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
    Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cilazapril on ventricular arrhythmia in patients with congestive heart failure.
    Hattori Y; Atsushi S; Hiroaki F; Toyama J
    Clin Ther; 1997; 19(3):481-6. PubMed ID: 9220212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of cilazapril in patients with essential hypertension.
    Karpov YA; Vilchinskaya MY; Sorokin EV; Podinovskaya VA
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S86-8. PubMed ID: 7700074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.
    Caminiti G; Volterrani M; Iellamo F; Marazzi G; Massaro R; Miceli M; Mammi C; Piepoli M; Fini M; Rosano GM
    J Am Coll Cardiol; 2009 Sep; 54(10):919-27. PubMed ID: 19712802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic L-arginine supplementation enhances endurance exercise tolerance in heart failure patients.
    Doutreleau S; Mettauer B; Piquard F; Rouyer O; Schaefer A; Lonsdorfer J; Geny B
    Int J Sports Med; 2006 Jul; 27(7):567-72. PubMed ID: 16802253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
    Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
    J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pressure-volume relationship during dobutamine stress echocardiography predicts exercise tolerance in patients with congestive heart failure.
    Ciampi Q; Pratali L; Bombardini T; Della Porta M; Petruzziello B; Villari B; Picano E; Sicari R
    J Am Soc Echocardiogr; 2010 Jan; 23(1):71-8. PubMed ID: 19962273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE; Sims R; Noakes TD
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients.
    Ding YA; Law HW; Chou TC
    J Hum Hypertens; 1994 Feb; 8(2):137-43. PubMed ID: 8207740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The acute effect of perindopril upon effort capacity in congestive heart failure.
    Zdrenghea D; Angheloiu O; Icusca G; Timiş D
    Rom J Intern Med; 1994; 32(4):265-9. PubMed ID: 7613498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
    von Haehling S; Schefold JC; Jankowska EA; Springer J; Vazir A; Kalra PR; Sandek A; Fauler G; Stojakovic T; Trauner M; Ponikowski P; Volk HD; Doehner W; Coats AJ; Poole-Wilson PA; Anker SD
    J Am Coll Cardiol; 2012 Feb; 59(6):585-92. PubMed ID: 22300693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of captopril on the exercise performance in patients with congestive heart failure].
    Han YL; Tong M; Miao ZL
    Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):281-3, 317. PubMed ID: 1478125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.